BALAXIPharmaceuticals
Balaxi Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹15.67
-9.20%
Current P/E13.86xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E11.9x16.5% above avg
✅
56.4% Discount to Industry
BALAXI P/E 13.86x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2023 | ₹9.08 | ₹86 | 9.5x |
| 2022 | ₹9.53 | ₹121 | 12.7x |
| 2021 | ₹7.63 | ₹103 | 13.5x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Balaxi Pharmaceuticals Ltd Valuation
Balaxi Pharmaceuticals Ltd (BALAXI) currently trades at 13.86x earnings. The Pharmaceuticals sector average PE is 31.77x. BALAXI is trading at a discount to peers — may indicate relative value. Historically, BALAXI has traded at an average PE of 11.9x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
11.61%
Dividend Yield
0.00%
More on Balaxi Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.